Toll Like Receptor 2 (TLR2) Antibody from ABBEXA LTD
Search, find, compare suppliers for anti-Toll Like Receptor 2 (TLR2) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Toll Like Receptor 2 (TLR2) |
| Clone | monoclonal |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | fluorescein (FITC) conjugate |
| Size | 100 µg, |
| Concentration | 0.1 mg/ml |
| Applications | FCM |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Toll-Like Receptor 2 (CD282) antibody (FITC) is a Mouse monoclonal antibody against Toll-Like Receptor 2 (CD282). |
| Immunogen | n/a |
| Other Names | TLR2, Toll Like Receptor 2, Toll/Interleukin-1 Receptor-Like Protein 4, Toll-Like Receptor 2, TIL4, CD282 Antigen, CD282, TLR2, TLR2, TLR2 , TLR2 , Toll Like Receptor 2, Toll Like Receptor 2, Toll Like Receptor 2 , Toll Like Receptor 2 , Toll/Interleukin-1 Receptor-Like Protein 4, Toll/Interleukin-1 Receptor-Like Protein 4, Toll/Interleukin-1 Receptor-Like Protein 4 , Toll/Interleukin-1 Receptor-Like Protein 4 , Toll-Like Receptor 2, Toll-Like Receptor 2, Toll-Like Receptor 2 , Toll-Like Receptor 2 , TIL4, TIL4, TIL4 , TIL4 , CD282 Antigen, CD282 Antigen, CD282 Antigen , CD282 Antigen , CD282, CD282, CD282 , CD282 |
| Gene, Accession # | TLR2, Gene ID: 7097, NCBI: NP_003255.2, UniProt: O60603 |
| Catalog # | abx414262 |
| Price | please inquire |
| Order / More Info | Toll Like Receptor 2 (TLR2) Antibody from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD
Return to Antibodies